WallStreetZenWallStreetZen

NYSE: PFE
Pfizer Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnershipStatistics

Analyst price target for PFE

Based on 12 analysts offering 12 month price targets for Pfizer Inc

Min Forecast
$25.00-3.7%
Avg Forecast
$29.50+13.64%
Max Forecast
$36.00+38.67%

Should I buy or sell PFE stock?

Based on 12 analysts offering ratings for Pfizer Inc.

Buy
Strong Buy
4 analysts 33.33%
Buy
1 analysts 8.33%
Hold
5 analysts 41.67%
Sell
1 analysts 8.33%
Strong Sell
1 analysts 8.33%
Our proven Zen Rating quant model agrees with analyst consensus with a "Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their PFE stock forecasts and price targets.

PFE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-04-29
lockedlocked$00.00+00.00%2026-04-20
lockedlocked$00.00+00.00%2026-04-16
lockedlocked$00.00+00.00%2026-04-13
lockedlocked$00.00+00.00%2026-04-10
Bank of America
Top 12%
89
HoldMaintains$26.00+0.15%2026-04-09
Guggenheim
Top 3%
98
Strong BuyMaintains$36.00+38.67%2026-03-24
HSBC
Top 33%
68
Strong BuyMaintains$32.00+23.27%2026-03-17
Argus Research
Top 21%
80
Strong BuyUpgrades$35.00+34.82%2026-03-02
Barclays
Bottom 50%
50
Strong SellInitiates Coverage On$25.00-3.70%2026-02-20

1 of 2

Forecast return on equity

Is PFE forecast to generate an efficient return?

Company
13.72%
Industry
20.67%
Market
170.14%
PFE's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PFE forecast to generate an efficient return on assets?

Company
5.95%
Industry
27.56%
PFE is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PFE earnings per share forecast

What is PFE's earnings per share in the next 3 years based on estimates from 30 analysts?

Avg 1 year Forecast
$2.99+128.5%
Avg 2 year Forecast
$2.84+117.13%
Avg 3 year Forecast
$2.49+89.85%
PFE's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

PFE revenue forecast

What is PFE's revenue in the next 3 years based on estimates from 30 analysts?

Avg 1 year Forecast
$62.0B-2.03%
Avg 2 year Forecast
$59.6B-5.85%
Avg 3 year Forecast
$55.3B-12.64%
PFE's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PFE earnings growth forecast

How is PFE forecast to perform vs Drug Manufacturers - General companies and vs the US market?

Company
24.52%
Industry
34.37%
Market
34.17%
PFE's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
PFE's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
PFE's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

PFE revenue growth forecast

How is PFE forecast to perform vs Drug Manufacturers - General companies and vs the US market?

Company
-4.18%
Industry
8.15%
Market
14.12%
PFE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PFE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PFE vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
PFE$25.96$29.50+13.64%Buy
GILD$133.05$161.46+21.35%Strong Buy
BMY$56.39$61.69+9.40%Buy
AMGN$336.45$362.38+7.71%Buy
SNY$42.42N/AN/A
View Top General Drug Manufacturer Stocks

Pfizer Stock Forecast FAQ

Is Pfizer Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 12 Wall Street analysts covering (NYSE: PFE) stock is to Buy PFE stock.

Out of 12 analysts, 4 (33.33%) are recommending PFE as a Strong Buy, 1 (8.33%) are recommending PFE as a Buy, 5 (41.67%) are recommending PFE as a Hold, 1 (8.33%) are recommending PFE as a Sell, and 1 (8.33%) are recommending PFE as a Strong Sell.

If you're new to stock investing, here's how to buy Pfizer stock.

What is PFE's earnings growth forecast for 2026-2028?

(NYSE: PFE) Pfizer's forecast annual earnings growth rate of 24.52% is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 34.37%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.17%.

Pfizer's earnings in 2026 is $7,490,000,000.On average, 30 Wall Street analysts forecast PFE's earnings for 2026 to be $17,060,146,231, with the lowest PFE earnings forecast at $15,639,274,800, and the highest PFE earnings forecast at $18,671,379,098. On average, 29 Wall Street analysts forecast PFE's earnings for 2027 to be $16,211,498,994, with the lowest PFE earnings forecast at $13,740,220,003, and the highest PFE earnings forecast at $18,515,784,272.

In 2028, PFE is forecast to generate $14,174,517,648 in earnings, with the lowest earnings forecast at $11,170,910,571 and the highest earnings forecast at $17,953,249,132.

What is PFE's revenue growth forecast for 2026-2028?

(NYSE: PFE) Pfizer's forecast annual revenue growth rate of -4.18% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 8.15%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.12%.

Pfizer's revenue in 2026 is $63,315,000,000.On average, 30 Wall Street analysts forecast PFE's revenue for 2026 to be $353,547,920,691,408, with the lowest PFE revenue forecast at $336,523,680,958,605, and the highest PFE revenue forecast at $374,219,804,692,371. On average, 30 Wall Street analysts forecast PFE's revenue for 2027 to be $339,755,265,802,428, with the lowest PFE revenue forecast at $312,540,419,895,453, and the highest PFE revenue forecast at $380,124,428,851,455.

In 2028, PFE is forecast to generate $315,241,956,431,559 in revenue, with the lowest revenue forecast at $277,175,368,826,808 and the highest revenue forecast at $359,925,598,716,519.

What is PFE's forecast return on assets (ROA) for 2026-2029?

(NYSE: PFE) forecast ROA is 5.95%, which is lower than the forecast US Drug Manufacturers - General industry average of 27.56%.

What is PFE's Price Target?

According to 12 Wall Street analysts that have issued a 1 year PFE price target, the average PFE price target is $29.50, with the highest PFE stock price forecast at $36.00 and the lowest PFE stock price forecast at $25.00.

On average, Wall Street analysts predict that Pfizer's share price could reach $29.50 by Apr 29, 2027. The average Pfizer stock price prediction forecasts a potential upside of 13.64% from the current PFE share price of $25.96.

What is PFE's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: PFE) Pfizer's current Earnings Per Share (EPS) is $1.31. On average, analysts forecast that PFE's EPS will be $2.99 for 2026, with the lowest EPS forecast at $2.74, and the highest EPS forecast at $3.28. On average, analysts forecast that PFE's EPS will be $2.84 for 2027, with the lowest EPS forecast at $2.41, and the highest EPS forecast at $3.25. In 2028, PFE's EPS is forecast to hit $2.49 (min: $1.96, max: $3.15).

What is PFE's forecast return on equity (ROE) for 2026-2029?

(NYSE: PFE) forecast ROE is 13.72%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.